A rat pheochromocytoma cell line (PC12) transfected with ganglioside GD3 synthase gene showed a marked change in the ganglioside profile and enhanced proliferation and no response of neurite extension to nerve growth factor (NGF) stimulation. In these transfectant cells, a continuous phosphorylation of TrkA and the activation of ERK1/2 without NGF treatment were observed. Proliferation inhibition experiments with kinase inhibitors such as herbimycin A, K-252a, and PD98059 revealed that the enhanced proliferation was actually due to the activation of the Ras/MEK/ERK pathway. A TrkA dimer was detected in the GD3 synthase transfectant cells regardless of NGF treatment by crosslinking and immunoblotting. The increased expression of GD1b and GT1b in these transfectant cells might induce the conformational change of TrkA to form a dimer and to be activated continuously. These results may indicate regulatory roles of gangliosides in cell proliferation under physiological and malignant processes.
A rat pheochromocytoma cell line (PC12) transfected with ganglioside GD3 synthase gene showed a marked change in the ganglioside profile and enhanced proliferation and no response of neurite extension to nerve growth factor (NGF) stimulation. In these transfectant cells, a continuous phosphorylation of TrkA and the activation of ERK1/2 without NGF treatment were observed. Proliferation inhibition experiments with kinase inhibitors such as herbimycin A, K-252a, and PD98059 revealed that the enhanced proliferation was actually due to the activation of the Ras/MEK/ERK pathway. A TrkA dimer was detected in the GD3 synthase transfectant cells regardless of NGF treatment by crosslinking and immunoblotting. The increased expression of GD1b and GT1b in these transfectant cells might induce the conformational change of TrkA to form a dimer and to be activated continuously. These results may indicate regulatory roles of gangliosides in cell proliferation under physiological and malignant processes.
Gangliosides, sialic acid-containing glycosphingolipids, are thought to play important roles in the development and function of the nervous system, since they are enriched in brain tissues of vertebrates and their profiles of carbohydrate moiety alter along with development (1, 2) . A number of glycosyltransferase genes have been isolated (3) , and studies of those genes have shown that various expression patterns of gangliosides are determined basically by the combination of activated glycosyltransferase genes.
GD3 is a disialylhematoside expressed mainly in the retina and fetal brain (4, 5) . GD3 synthase is characteristically expressed in the early developmental stage of brain tissues (4, 6) . Since the GD3 synthase gene was isolated (7) , the mRNA expression of the gene has been directly examined, and high expression levels in the early stage of development have been demonstrated in mouse (8) and rat brain (9) . GD3 synthase gene was strongly expressed in the neural tube at embryonal day 9, whereas the GM2/GD2 synthase gene was not detected at all at this stage (8) . These results suggest that GD3 is involved mainly in the neuronal proliferation and the subsequent processes of differentiation such as neurite extension and synapse formation (10) . Accordingly, the expression level of GD3 synthase gene is low after birth (8) , and GD3 could scarcely be detected in the adult brain, except for the choroid plexus (11) .
GD3 was also identified as a melanoma-specific antigen (12) . Not only established melanoma cell lines but all primary melanoma tissues contained a high amount of GD3 as a major ganglioside component (13) . In contrast, human melanocytes, the normal counterpart of melanoma cells, expressed none or minimal levels of GD3 (14) . These findings suggest that GD3 might play important roles in the transformation of melanocytes into melanomas and also in the maintenance of malignant characteristics of melanoma cells. A melanoma mutant line lacking GD3 expression was found to show a slower growth rate and a lesser motility compared with the parent line fully expressing GD3 (15) .
In fact, the anti-GD3 monoclonal antibody R24 has been applied for the therapy of melanoma patients (16) . During this clinical study, human T cells were observed to express GD3, when activated by various mitogens and cytokines (17, 18) . Anti-GD3 mAb 1 R24 itself also induced T cell activation. These findings suggest that GD3 is involved in the activation of T lymphocytes and might emit cellular signals inducing T cell proliferation. In addition, GD3 expression was observed in T cell acute lymphoblastic leukemia cells (19, 20) and adult T cell leukemia cells (21) . These T cell leukemias are extraordinarily aggressive and resistant to current therapy, indicating that GD3 might play essential roles in their malignant features.
Rat pheochromocytoma PC12 cells are widely used as a differentiation model of neuronal cells, since they show neurite extension after nerve growth factor (NGF) stimulation. The ganglioside GM1 enhanced the effect of NGF on the induction of differentiation (22) . GM1 also can prevent the death of PC12 cells caused by serum deprivation (23) . Mutoh et al. (22) demonstrated that GM1 bound to TrkA and enhanced its kinase activity, suggesting that gangliosides interact with growth (or differentiation) factor receptors and modulate their functions. Kasahara et al. (24) also reported that GD3 associates with Lyn kinase physically and functionally on the surface of primary cerebellar neurons.
In the present study, we have tried to modulate the ganglioside composition of PC12 cells by introducing glycosyltransferase genes to analyze the regulatory functions of gangliosides in the cellular signaling for proliferation and/or differentiation. To our surprise, PC12 cells transfected with GD3 synthase cDNA showed a marked increase of cell growth and an inability to respond to NGF stimulation. We have studied the molecular mechanisms underlying the continuous proliferation of the GD3 synthase gene transfectant cells. The novel findings in PC12 transfectant cells may indicate universal roles of gangliosides in the regulation of cell growth/differentiation, in the tissue development, and the malignant transformation of cells.
EXPERIMENTAL PROCEDURES
Cell Culture-The rat pheochromocytoma cell line PC12 was maintained in RPMI 1640 supplemented with 10% horse serum, 5% fetal bovine serum, 100 units/ml penicillin and streptomycin at 37°C in a humidified atmosphere containing 5% CO 2 . For the neurite outgrowth assay, PC12 cells were seeded in the above growth medium at 1 ϫ 10 5 cells/well in type I collagen-coated 48-well culture plates (Falcon, Lincoln Park, NJ) and allowed to grow for 24 h. Cells were either treated with 100 ng/ml 2.5S NGF (Alamone Labs, Jerusalem, Israel) in serumfree medium or were left untreated in the above medium. Neuritebearing cells were counted on the 1st to the 4th day of culture.
Recombinant DNA Construction-Human ␣2,8-sialyltransferase cDNA clone pD3T-31 (7) was digested by XhoI and inserted into the XhoI site of pMIKneo to obtain the pMIKneo/D3T-31. pMIKneo is a mammalian expression vector with SR␣ promoter and was generously provided by Dr. K. Maruyama (Tokyo Medical and Dental University).
Gene Transfection and Selection-PC12 cells used for cDNA transfection were plated in a 60-mm plastic tissue culture plate (Falcon) at a density of 7 ϫ 10 5 cells/4 ml/plate. After 48 h, the medium was removed, and the cells were washed twice with serum-free Dulbecco's modified Eagle's medium. The pMIKneo/D3T-31 vector (4 g) was mixed with LipofectAMINE (Life Technologies, Inc.) and then added to PC12 cells in the plates. After a 6-h incubation, the medium was changed to the regular one as described above. Stable transfectants were selected with 250 g/ml G418 (Sigma).
Cell Proliferation and BrdUrd Incorporation-One ϫ 10 5 cells/ml/ well were plated in collagen-coated 48-well plates on day 1 of culture. Cell numbers were counted by the trypan blue dye exclusion method up to day 5. For the bromodeoxyuridine (BrdUrd) incorporation assay, cells were incubated at the cell density described above for 16 h prior to the addition of 100 M BrdUrd (Sigma). After an additional 6-h incubation, the cells were fixed with cold methanol for 10 min, rehydrated in phosphate-buffered saline (PBS), and incubated for 30 min in 1.5 M HCl in order to denature the DNA. After being washed three times in PBS, the plates were incubated with a 1:50 dilution of a fluorescein-isothiocyanate (FITC)-conjugated anti-BrdUrd antibody (PharMingen, San Diego, CA) for 30 min at room temperature. Finally, the cells were washed in PBS three times and incubated with 10 g/ml propidium iodide (Sigma) in PBS for 30 min at room temperature.
Flow Cytometry-The cell surface expression of gangliosides was analyzed by flow cytometry (Becton Dickinson, Mountain View, CA), using the anti-ganglioside monoclonal antibodies (mAb) M2590 (anti-GM3), mAb 10 -11 (anti-GM2, kindly provided by Dr. P. O. Livingston of the Memorial Sloan-Kettering Cancer Center), mAb CDR73-6 (antifucosyl-GM1, generously provided by Dr. S. Kusunoki, Tokyo University), mAb 92-22 (anti-GD1a), mAb R24 (anti-GD3, kindly provided by Dr. L. J. Old of the Memorial Sloan-Kettering Cancer Center), mAb 3F8 (anti-GD2, generously provided by Dr. N. K. Cheung of the SloanKettering Cancer Center), mAb 370 (anti-GD1b), mAb 549 (anti-GT1b), and mAb GMR-13 (anti-GQ1b, kindly provided by Dr. Tai of the Tokyo Metropolitan Institute for Medical Research). Unless described otherwise, the antibodies were generated in our laboratory (25) . The cells were incubated with mAbs for 45 min on ice and then stained with FITC-conjugated goat anti-mouse IgM or IgG (Cappel, Durham, NC). To analyze GM1, cells were incubated with biotin-conjugated cholera toxin B subunit (List Biological Laboratories, Campbell, CA) for 45 min on ice and then stained with FITC-conjugated avidin (EY Laboratories, San Mateo, CA). Control cells for flow cytometry were prepared by using the second antibody alone.
␣2,8-Sialyltransferase
Enzyme Assay-The enzyme activity of ␣2,8-sialyltransferase was measured as described previously (26) . Briefly, to prepare membrane fractions, samples were lysed using a nitrogen cavitation apparatus. For the analysis of the enzyme activity of ␣2,8-sialyltransferase, the reaction mixture contained the following in a volume of 50 l: 100 mM sodium cacodylate HCl, pH 6.0, 10 mM MgCl 2 , 0.3% Triton CF-54 (Sigma), 325 M GM3, 400 mM CMP-NeuAc (Sigma), CMP-[ 14 C]NeuAc (2.5 ϫ 10 5 dpm) (NEN Life Science Products), and the membrane fractions containing 50 g of protein. The products were isolated by a C18 Sep-Pak cartridge (Waters, Milford, MA) and analyzed by thin layer chromatography (TLC) and fluorography as described (27) .
Protein Kinase Inhibitor Assay-Serum-deprived PC12 cells in 48-well plates were treated with various inhibitors in the conditions as described below. Cells were treated with 50 M PD98059 (a MEK inhibitor, New England Biolabs, Beverly, MA) for 30 min, 0.5 M K-252a (a Trk tyrosine kinase inhibitor, kindly provided by Kyowa Medex Co., Tokyo, Japan) for 30 min, or 0.5 g/ml herbimycin A (a tyrosine kinase inhibitor, a generous gift from Dr. Uehara, Japanese National Institute of Health) for 1 h prior to the addition of serumcontaining medium. Cells were treated with 1 M wortmannin (a PI3 kinase inhibitor, Sigma) for 30 min prior to the addition of serumcontaining medium, and then it was added every 12 h for 5 days.
Western Immunoblotting-PC12 cells and transfectants were plated in 60-mm tissue culture plates in serum-containing medium. Before NGF treatment, the medium was replaced with serum-free medium, and the cells were incubated for 1 h. The cells were then incubated with 100 ng/ml 2.5 S NGF for the appropriate times in the individual experiments at 37°C. After this treatment, the medium was removed, and the cells were washed three times with 3 ml of serum-free medium and then solubilized in 200 l of lysis buffer (10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 10 mM MgCl 2 , 0.5% Nonidet P-40, 1 mM phenylmethylsulfonyl fluoride, 20 units/ml aprotinin). Lysed cells were centrifuged at 3,000 rpm for 10 min, and then lysates were subjected to 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Proteins were transferred electrophoretically onto a polyvinylidene difluoride membrane (Millipore) and immunoblotted with antibodies reactive with either neurofilament-M (Affinity Products), GD3 synthase (kindly presented by Dr. Y. Sanai at Tokyo Research Institute of Clinical Medicine), and MAPK (or ERK1/2) or phospho-MAPK (New England Biolabs).
TrkA Immunoprecipitation-Immunoblot-Cells were treated with NGF (100 ng/ml) for appropriate times indicated at 37°C and then washed with cold PBS containing 1 mM Na 3 VO 4 and lysed with lysis buffer described above. Lysates were immunoprecipitated with antiTrkA antibody C-14 (Santa Cruz Biotechnology, Santa Cruz, CA). The precipitates were washed in lysis buffer 3 times, then were subjected to 7.5% SDS-PAGE, and immunoblotted with anti-phospho-TrkA antibody (New England Biolabs) or anti-TrkA antibody (C-14). The individual bands were detected by peroxidase-conjugated anti-rabbit IgG (New England Biolabs) combined with the ECL kit (Amersham Pharmacia Biotech).
Protein Cross-linking and Immunoprecipitation-Cells were plated in 100-mm culture plates (Falcon) at a density of 5 ϫ 10 6 cells/plate and cultured in serum-containing medium for 48 h. Before NGF treatment, the medium was replaced with serum-free medium, and the cells were incubated for 1 h. The cells were then incubated with 100 ng/ml 2.5 S NGF for 60 min at 4°C. After treatment, the medium was removed, and the cells were washed three times with 3 ml of ice-cold PBS containing 1 mM Na 3 VO 4 (Sigma). The chemical cross-linker BS3 (Pierce) was added up to 2 mM in cross-linker buffer (25 mM HEPES, pH 7.4, 120 mM NaCl, 6 mM KCl, 1 mM MgCl 2 , 10 mM EGTA). Cross-linked cells were lysed with lysis buffer (20 mM Tris-HCl, pH 7.4, 1% Nonidet P-40, 10% glycerol, 50 mM NaF, 1 mM Na 3 VO 4 , 1 mM phenylmethylsulfonyl fluoride, 10 g/ml leupeptin). The cell-free lysates were adjusted to the same protein concentration and immunoprecipitated with an anti-Trk antibody C-14 according to the manufacturer's instructions. The precipitate was subjected to 7.5% SDS-PAGE, electroblotted, and then analyzed as described above. A monoclonal phosphotyrosine antibody PY20 was used for the detection of phosphorylated tyrosine residues according to manufacturer's protocol. The bands were detected by peroxidase-conjugated anti-mouse IgG (Zymed Laboratories Inc., San Francisco, CA).
RESULTS

Expression of Transfected GD3 Synthase Gene-After the transfection of PC12 cells with GD3 synthase expression vector
Proliferation of GD3 Synthase Gene-transfected PC12
pMIKneo/D3T-31 or pMIKneo alone, PC12/D3T-1 and -2 and vector control lines PC12V-1 and -2 cells were established. The increased levels of GD3 synthase activity (Fig. 1A ) and its expression (Fig. 1B) were confirmed by enzyme assay and Western immunoblotting, respectively. To analyze the change of ganglioside profiles by the introduction of GD3 synthase gene, we performed a flow cytometric analysis. Among the gangliosides examined, the expression levels of GM1 and fucosyl-GM1 (major gangliosides in the parent cells) were reduced in the transfectants. The GD1b and GT1b levels were markedly increased in the transfectant cells (Fig. 1C) . The ganglioside profiles of the control transfectants showed no changes (data not shown).
Morphology and Response to NGF Treatment of GD3 Synthase Gene Transfectant Cells-These transfectant cells showed essentially no change in morphology compared with the parent cells or vector control cells (Fig. 2A) . When they were stimulated by NGF, the GD3 synthase transfectants did not show any neurite formation and kept their original round shape, whereas the parent cells and vector control cells responded to NGF by extending neurites. In addition to the neurite formation, the expression of neurofilament-M was analyzed as a biochemical marker of neuronal differentiation. Although the parent PC12 cells showed an ϳ10 times increase of a neurofilament-M band after NGF treatment, the PC12/ D3T-1 cells showed almost equal intensities of neurofilament-M bands before and after NGF treatment in accord with the results of neurite formation (Fig. 2B) .
The quantitative analysis of the neurite formation revealed that only 5-10% of the PC12/D3T cells showed neurites, a less than 2-fold length of cell diameter even at day 4 of culture ( Fig.  3) . About 25% of the PC12 cells transfected with vector alone showed neurites of lengths more than 2-fold the cell diameter, and neurites less than 2-fold the diameter were seen in more than 25% of the cells.
Proliferation of GD3 Synthase Gene Transfectants-The proliferation of the GD3 synthase gene transfectants and the control vector transfectants was compared. As shown in Fig. 4A , the GD3 synthase gene transfectants showed tremendously rapid growth. The numbers of these transfectants were 4 -5 times higher than those of the parent PC12 cells and vector transfectants at day 4 of culture. The BrdUrd incorporation was compared by staining with a specific antibody. In the presence of serum, the percentage of BrdUrd-positive GD3 synthase gene transfectant cells was about 1.8 times the control cell value (Fig. 4B) . In the absence of serum, the transfectant cells still showed much better proliferation than controls (Fig. 4C) . When NGF was added, the transfectants showed slightly higher BrdUrd-positive rate than in non-serum condition, whereas the control cells also showed a little higher BrdUrd-positive cells (Fig. 4D) .
Phosphorylation of MAPKs and TrkA NGF Receptor-To analyze the alteration of NGF receptor TrkA and its downstream signaling molecules, the activation of extracellular signal-reg- ulated kinases (ERK1 and ERK2) was examined by Western immunoblotting. As expected, both ERK1 and ERK2 were activated after NGF treatment in the parent cells and a vector control cell line (PC12V-1) (Fig. 5A, upper left) . Surprisingly, the GD3 synthase gene transfectant cells showed strong activation regardless of NGF stimulation (Fig. 5A, upper right) . The Western immunoblots with anti-MAPK demonstrated that the lysates applied contained equivalent amounts of total ERK proteins, and ERK1 was more efficiently phosphorylated than ERK2 (Fig. 5A, lower) .
The time course of the tyrosine phosphorylation of TrkA after NGF treatment was analyzed using immunoprecipitates and an anti-phospho-TrkA antibody. The parent cells and the vector controls showed a definite phosphorylation only after NGF treatment and then gradually reduced (Fig. 5B , upper, data of PC12/V-1 are shown). In contrast, the GD3 synthase gene transfectant cells showed consistent strong bands before and after NGF treatment (Fig. 5B, lower) . The intensity of these phosphorylated bands was persistently strong regardless of NGF treatment for more than 2 h. The bottom of each panel illustrates the equal amounts of precipitated TrkA protein.
The time course of MAPK phosphorylation then was examined. As shown in Fig. 5C , both ERK1 and ERK2 were consistently phosphorylated regardless of NGF treatment in PC12/ D3T-1, whereas they were phosphorylated only after NGF treatment, and then the activation levels gradually reduced in the vector controls. All these data corresponded with those of TrkA.
Proliferation Signals Are Transduced by the TrkA/Ras/ MEK/ERK Pathway-To identify the signaling pathway that is involved in the enhanced proliferation in the GD3 synthase gene transfectant cells, the effects of various inhibitors of signaling molecules on the cell proliferation were analyzed. Treatment with the tyrosine kinase inhibitor herbimycin A resulted in a complete suppression of the cell growth of parent PC12, PC12V-1, PC12/D3T-1, and PC12/D3T-2 cells (Fig. 6A) . Effects of this inhibitor on TrkA and MAPK were confirmed in Western immunoblots, i.e. complete suppression of TrkA phosphorylation (Fig. 6D) and reduction of MAPK activation to the control level (Fig. 6E) . When the Trk inhibitor K252a was used, no significant growth suppression was observed in the parent cells or the vector control transfectant cells (Fig. 6B) . In contrast, in the GD3 synthase gene transfectant cells, cell growth was markedly suppressed to the levels of parent PC12 or vector control transfectants. In this condition of the inhibition, the majority of the phosphorylation in TrkA and MAPK was suppressed (Fig. 6, D and E) . When the MEK inhibitor PD98059 was added, MAPK activation was markedly suppressed compared with the samples with no inhibitor (Fig. 6E) . Under this condition, it showed almost no effect on the parent cells or vector control transfectants (Fig. 6C) ; however, in the GD3 synthase gene transfectant cells, rapid cell growth was strongly suppressed, but their growth was still better than that of the parent and control cells. The effect of the PI3 kinase inhibitor wortmannin was examined; it showed only mild growth suppression in the GD3 synthase gene transfectants, and no effect on the parent and vector control cells (data not shown). Thus, it   FIG. 4 . Proliferation of GD3 synthase gene transfectants. A, cell numbers were counted by a trypan blue exclusion method at days 1, 3, and 5 of culture. BrdUrd incorporation for 6 h when cultured in RPMI 1640 supplemented with 10% horse serum and 5% fetal bovine serum (B) or when cultured with (D) or without (C) 100 ng/ml NGF in serumfree medium after serum deprivation for 60 min. Cells were prepared, counted, and stained as described under "Experimental Procedures." Note that GD3 synthase gene transfectant cells showed definite growth even without serum and NGF for a short time as observed in this assay (C). Mean values Ϯ S.D. (n ϭ 3) are presented.
FIG. 5. Continuous phosphorylation of TrkA and MAPKs (ERK1/2).
A, MAPK activation before and after NGF treatment. Cells were treated by NGF for 5 min and then served for immunoblotting with an anti-phosphorylated MAPK antibody (upper) or an anti-MAPK antibody (ERK1/2) (lower) as described under "Experimental Procedures." B, the time course of the phosphorylation levels of TrkA in the transfectants was analyzed. PC12/V-1 and PC12/D3T-1 were treated with 100 ng/ml NGF for the times indicated. TrkA was immunoprecipitated with an anti-Trk antibody (C-14), and immunoblotting was carried out using anti-phospho-TrkA (upper in each panel) or anti-TrkA (lower) as indicated in the figure. C, activation of MAPKs. Cells were treated as described in B and then were lysed with Nonidet P-40 lysis buffer, and total lysates were separated by 12% SDS-PAGE. Western blotting was carried out using an anti-phosphorylated MAPK antibody (upper) or an anti-MAPK (lower) as described under "Experimental Procedures." Experiments shown in A and C were repeated more than five times, and those in B were repeated three times with similar results.
was demonstrated that the increased proliferation of the GD3 synthase gene transfectants depended on Trk/Ras/ERK pathway.
Dimerization of TrkA Molecules on the Cell Surface-To analyze the molecular changes of TrkA in the GD3 synthase gene transfectants, the presence of the dimerized form of TrkA was examined by the cross-linking of TrkA with or without NGF treatment. In the parent PC12 and a vector control clone, dimerized high molecular weight bands were detected only after NGF treatment by an anti-phosphotyrosine antibody (Fig.  7) . In contrast, in the GD3 synthase gene transfectant cells, dimerized bands existed without NGF stimulation and showed no significant changes in the intensity after NGF treatment.
DISCUSSION
There have been a number of reports on the modulation of cell growth and/or differentiation by glycosphingolipids (28) . Many of these studies were performed by adding exogenous glycolipids into the culture medium of cell lines under investigation. The modulation of functions of platelet-derived growth factor receptor (29) , epidermal growth factor receptor (30, 31) , insulin receptor (32), insulin-like growth factor receptor (33) , and NGF receptor (22) has been reported. In the majority of these studies, the gangliosides added suppressed the receptor functions based on the reduced phosphorylation of receptor molecules. Few studies have analyzed the effects of endogenously generated gangliosides (34) on the functions of growth factor receptors. Our present study is thus quite novel as a functional analysis of glycosphingolipids by the genetic modification of their carbohydrate structures.
PC12 cells show neuronal differentiation by neurite extension when stimulated by NGF (35) . The main signals involved in this differentiation are transduced through TrkA phosphorylation at tyrosine residue 490, the subsequent Shc binding and Ras/Raf/MEK activation, and then ERK1/2 activation (36 -38). The ganglioside GM1 has been reported to bind to TrkA and enhances the TrkA response to NGF stimulation, resulting in higher autophosphorylation (22) , more dimerization (39), and better differentiation. In these cases, added GM1 did not change the time course of the signal transduction or the fate of PC12 cells but just regulates the reactivity of Trk receptor to NGF.
In the GD3 synthase gene transfectants, modulation of the ganglioside profile resulted in an unexpected change in the quality of the signal pathway and a marked change of the cell fate. The new findings in the transfectant cells elucidated in this study are summarized as follows. First, continuous and autonomous TrkA phosphorylation and ERK1/2 activation without NGF treatment were observed. Second, the cells showed complete unresponsiveness to NGF in terms of neuronal differentiation. Third, the alteration of signal molecules resulted in the enhanced proliferation of the cells. Fourth, the results of experiments with inhibitors of various kinases revealed that the increased cell growth of the GD3 synthase gene transfectants depended on the activation of TrkA and ERKs which are involved in the differentiation of the parent PC12 cells. Fifth, persistent dimerization of TrkA regardless of NGF stimulation existed.
How can the TrkA/Ras/ERK pathway be involved in both cell differentiation and proliferation? What is different in the signal pathway between NGF-treated PC12 and GD3 synthase gene transfectant cells? First, the activation time course of signaling might be critical. For signals through epidermal growth factor receptor leading PC12 to proliferation, a relatively short term activation of the Ras/MEK/MAPK pathway as detected by ERK activation induced PC12 cells to proliferate (40) , whereas relatively long-acting signals (e.g. by NGF) led the cell line to differentiation. In contrast, ERK1/2 was continuously activated and sustained at highly activated levels in the GD3 synthase gene transfectant cells, resulting in markedly increased proliferation. These findings indicate that the duration of the Ras/MEK/ERK pathway activation may not be an absolute factor to determine the cell fate. The magnitude of their activation might be more important. Second, modification of ganglioside components may cause the activation of another signaling pathway. Besides the TrkA/Ras/MEK/ERK pathway, phospholipase C␥ and PI3 kinase are also activated via Trk phosphorylation. Furthermore, other growth factor receptors, such as epidermal growth factor receptor and platelet-derived growth factor receptor, might be activated by the carbohydrate modulation, although the kinase inhibition assay indicated the involvement of TrkA/ERK in the increased proliferation.
GD1b and GT1b were the main species generated at higher rates after the introduction of GD3 synthase gene compared to before the introduction. Therefore, these two species might trigger the abnormal activation of the TrkA/ERK pathway by modulating the conformation of the TrkA molecule. Actually, GD1b and GT1b showed interesting and different effects on the proliferation and differentiation (data not shown) when exogenously added. Another point we need to consider is the effects of GM1 reduction, because addition of GM1 to the transfectant cells restored the reactivity to NGF in terms of TrkA activation (data not shown).
In any case, the dimer formation of TrkA in the GD3 synthase gene transfectant cells as demonstrated here suggested that newly expressed and/or reduced gangliosides might modify the conformation of the TrkA molecule, resulting in the dimerization without NGF binding. The questions of 1) whether these gangliosides bind to TrkA and 2) what are the mechanisms underlying the conformational change and the dimer formation of TrkA in the presence of GD1b/GT1b are now under investigation in our laboratory.
The results obtained in this study strongly suggested the important roles of endogenously generated gangliosides in the regulation of cell differentiation/proliferation. To clarify the molecular mechanisms for the regulatory role of GD3, it seems important to investigate the nuclear transport of ERK1/2 (40) and the internalization of the TrkA molecule (41) in addition to the activation of individual signaling molecules in these transfectant cells.
The differences of the resulting effects of GD3 synthase gene transfection between PC12 as shown here and Neuro2a (34, 42) might be due to the differences in the profiles of pre-existing gangliosides in each cell line. Moreover, levels of expressed and activated transcription factors, which ERK1/2 regulates in individual cells such as c-Jun (43) , and a helix-loop-helix protein HES 1 (44) are critical for the determination of cell fates and remain to be investigated.
